Company Overview of U.S. Venture Partners
U.S. Venture Partners is a venture capital firm specializing in investments in startup, early-stage, late venture, and growth capital. It typically invests in information technology, health care, life science and technologies for adapting to or mitigating climate change with a focus on energy-related products and services, components, digital communications, software, enterprise, SaaS, security software systems, mobile and wireless semiconductor, web-enabled services for businesses and consumers, storage, wireless communication, data center, network systems and technology, consumer and business services, media, clean technologies, sustainable agriculture, the Internet version 2.0, biomedical...
2735 Sand Hill Road
Menlo Park, CA 94025
Founded in 1981
Key Executives for U.S. Venture Partners
Founding Partner and Senior Advisor
Compensation as of Fiscal Year 2014.
U.S. Venture Partners Key Developments
U.S. Venture Partners Presents at 12th Annual BIO Investor Forum, Oct-08-2013
Oct 4 13
U.S. Venture Partners Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.
U.S. Venture Partners Promotes Jacques Benkosk to Partner
May 30 13
U.S. Venture Partners announced the firm expanded its team by promoting Dr. Jacques Benkoski to Partner and adding two new EIRs, Mike Maciag and Craig Parker. Since 2005, Jacques has been involved with USVP investments in Chute, HelloFax, Plumgrid, Qnovo, Quixey, RiskIO, SupplyFrame, in addition to his active involvement with Israeli companies Trusteer, Zerto, and previously Dune Networks. He is currently Chairman of the Silicon Valley Chapter of the American Technion Society, and an active board member of the California Israel Chamber of Commerce. An Executive-in-Residence for USVP, Mike Maciag served as the CEO of Electric Cloud for over seven years. Craig Parker joins USVP as an Entrepreneur-in-Residence. Craig was the SVP of Corporate Development and Strategy for Human Genome Sciences. Previously, he was SVP of Corporate Development and Finance at Proteolix, a USVP portfolio company.
Similar Private Companies By Industry
Recent Private Companies Transactions